Engelsk titel: A survey of various adjuvant treatments used against type 1 diabetes, focusing on SGLT2 inhibitors
Läs online
Författare:
Sjöholm, Åke
Email: ake.sjoholm@regiongavleborg.se
Språk: Swe
Antal referenser: 44
Dokumenttyp:
Översikt
UI-nummer: 19060082
Sammanfattning
Insulin and its analogues have so far and for almost 100 years been the only officially approved treatment for type 1 diabetes in Europe. However, in clinical practice, various drugs against type 2 diabetes have sometimes been used off label as adjuvants to insulin for type 1 diabetes. Recently, the EMA approved the SGLT2 inhibitor dapagliflozin as an adjuvant treatment for type 1 diabetes in adults. This article is a survey of various adjuvant treatments used against type 1 diabetes, focusing on SGLT2 inhibitors and their pros and cons.